Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Contraceptive Technology Update

RSS  

Articles

  • HPV vaccine research yields promising results

    What if you could offer your patients a vaccine for protection against human papillomavirus (HPV), a sexually transmitted disease (STD) that can cause genital warts and cervical cancer? Just-published results from a randomized double-blind study indicates that an investigational vaccine developed by West Point, PA-based Merck & Co. reduced the incidence of human papillomavirus type 16 (HPV 16) infection in 100% of women who previously had not been infected with the STD.
  • A Review of Extended-Cycle Oral Contraception

    Seasonale (Barr Laboratories, Pomona, NY), the first extended-cycle oral contraceptive (12 weeks continuous daily active pill followed by a one-week inactive pill) approved by the Food and Drug Administration (FDA) is expected to become clinically available by the end of this month.
  • CTU Updates

    ACNM web site offers breast-feeding resources; New condom now available from Trojan; New Arabic web site offers EC information
  • Emergency contraception provision catches on

    Just six years ago, a national report asked, Is the secret getting out? when it comes to emergency contraception (EC).1 If results of the 2003 Contraceptive Technology Update Contraception Survey are any indication, ECs message now is being heard loud and clear.
  • Readers share views on common OC challenges

    The next patient on your schedule is a 41-year-old woman who smokes 12-15 cigarettes a day. She would like to use combined oral contraceptives (OCs). Will she leave your office with a prescription for the Pill?
  • Survey profile

    A total of 215 providers participated in the 2003 Contraceptive Technology Update Contraception Survey, which monitors contraceptive trends and family planning issues among readers.
  • Move over, Pill: New contraceptives expand acceptance among women

    When discussing contraceptive options with your female patients, what choices are available at your facility? If they include the contraceptive patch (Ortho Evra, Ortho-McNeil Pharmaceutical, Raritan, NJ) and the contraceptive vaginal ring (NuvaRing, Organon, West Orange, NJ), you join the majority of respondents to the 2003 Contraceptive Technology Update Contraception Survey.
  • Audio conference looks at revolutionary contraceptive

  • Readers rank top oral contraceptives

    While new birth control methods are attracting attention from new and established contraceptive users, family planning clinicians say many women continue to choose combined oral contraceptives (OCs) for safe, reliable pregnancy prevention.
  • Interest in extended-use contraception to grow

    Get ready for a major change to occur in the way birth control pills are prescribed and used with the arrival of Seasonale, the first dedicated extended-regimen oral contraceptive.